ENTITY
Acadia Pharmaceuticals

Acadia Pharmaceuticals (ACAD US)

23
Analysis
Health CareUnited States
ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.
more
Company Event26 Feb 2026 05:30 • Upcoming
Add To Calendar
Company Event02 Dec 2025 22:45 • Latest
Company Event11 Nov 2025 03:00
Company Event06 Nov 2025 05:30
x